Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-02-09

Clinical Trial Update: Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a regimen of celecoxib, leucovorin, fluorouracil, and oxaliplatin for metastatic colorectal cancer; the current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)
  • FLUOROURACIL (Fluorouracil)
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN